A metanalysis by Kyriakou et al. showed a significant reduction in resistin levels in psoriasis patients after topical and systemic treatment, which may have clinical relevance in terms of using resistin to assess the severity of the inflammatory process [40]. This evidence concerns the gene RETN and psoriasis.